Retrophin, Inc. | Uncategorized | Business Contracts

Amendment No. 3 to Sublicense Agreement dated as of February 27, 2015, between the Company and Ligand Pharmaceuticals Incorporated (Filed With SEC on February 24, 2022)

Amendment No. 4 to Sublicense Agreement dated as of September 17, 2015, between the Company and Ligand Pharmaceuticals Incorporated (Filed With SEC on February 24, 2022)

Underwriting Agreement, dated September 5, 2018, by and among the Company, Jefferies LLC, and Barclays Capital Inc (Filed With SEC on September 10, 2018)

Base Indenture, dated September 10, 2018, between the Company and U.S. Bank National Association, as Trustee (Filed With SEC on September 10, 2018)

First Supplemental Indenture, dated September 10, 2018, between the Company and U.S. Bank National Association, as Trustee (including the form of 2.50% Convertible Senior Note due... (Filed With SEC on September 10, 2018)

Form of Indemnity Agreement (Filed With SEC on May 1, 2018)

Amendment No. 5 to Sublicense Agreement dated as of March 20, 2018, between the Company and Ligand Pharmaceuticals Incorporated (Filed With SEC on May 1, 2018)

Employment Agreement, dated February 13, 2017, and Amendment to Employment Agreement, dated April 11, 2017, by and between the Company and William Rote (Filed With SEC on May 1, 2018)

Employment Agreement, dated February 6, 2017, and Amendment to Employment Agreement, dated April 11, 2017, by and between the Company and Elizabeth E. Reed (Filed With SEC on May 1, 2018)

Amendment Two to the Third Amendment to Trademark License and Supply Agreement, dated November 3, 2017, by and between the Company and Mission Pharmacal Company (Filed With SEC on February 27, 2018)

RETROPHIN, INC. Amendment to Employment Agreement (Filed With SEC on May 5, 2017)

2017 Retrophin, Inc. Executive Officer Annual Bonus Plan (Filed With SEC on March 1, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on November 4, 2016)

AMENDMENT ONE TO THE THIRD AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2016)

ASSET PURCHASE AGREEMENT (Filed With SEC on August 5, 2016)

SECOND AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT (Filed With SEC on May 5, 2016)

THIRD AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT (Filed With SEC on May 5, 2016)

AMENDMENT NO. 4 TO SUBLICENSE AGREEMENT (Filed With SEC on November 6, 2015)

ASSET PURCHASE AGREEMENT BY AND BETWEEN SANOFI AND RETROPHIN, INC. May 22, 2015 ASSET PURCHASE AGREEMENT (Filed With SEC on May 27, 2015)

ASSET PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)

Amendment No. 3 to Credit Agreement (Filed With SEC on May 11, 2015)

AMENDMENT NO. 3 TO SUBLICENSE AGREEMENT (Filed With SEC on May 11, 2015)

ASSET PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)

Amendment No. 4 to Credit Agreement (Filed With SEC on May 11, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on May 11, 2015)

PURCHASE AGREEMENT (Filed With SEC on May 11, 2015)

6,840,000 Shares RETROPHIN, INC. CommonStock, Par Value $0.0001 Per Share UNDERWRITING AGREEMENT (Filed With SEC on March 19, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2015)

Summary SeparationProposal (Filed With SEC on March 11, 2015)

$45,000,000 CREDIT AGREEMENT dated as of June 30, 2014 among RETROPHIN, INC., as Borrower, the LENDERS from time to time parties hereto and U.S. BANK NATIONAL ASSOCIATION, as... (Filed With SEC on November 13, 2014)

Amendment No. 1 to Credit Agreement (Filed With SEC on November 13, 2014)

Amendment No. 2 to Credit Agreement (Filed With SEC on November 13, 2014)

FIRST AMENDMENT TO TRADEMARK LICENSE AND SUPPLY AGREEMENT (Filed With SEC on July 29, 2014)

COMMON STOCK PURCHASE WARRANT CERTIFICATE RETROPHIN, INC. Warrants: _______Initial Exercise Date: June 30, 2014 (Filed With SEC on July 7, 2014)

Retrophin, Inc. (118) | Uncategorized (78)